M, C., I, B., E, F., J, G. G., L, R., MT, D. P., . . . JP, G. (2022). Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Citación estilo ChicagoM, Chaparro, et al. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study. 2022.
Cita MLAM, Chaparro, et al. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study. 2022.
Precaución: Estas citas no son 100% exactas.